Welcome to the NICE Decision Support Unit

The latest news from the DSU


Treatment switching TSD
TSD 16: Adjusting survival time estimates in the presence of treatment switching (July 2014)

Bevacizumab for eye conditions 
Publication: The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review (July 2014)

Patient-level simulation TSD
TSD 15: Cost-effectiveness modelling using patient-level simluation (April 2014)

Value based pricing / assessment
4 DSU reports on the implementation of value based pricing (now value based assessment)

Mapping of EQ-5D
Publication: A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes (Sept 2013)

Regression methods
Publication: Good practice guidelines for the use of statistical regression models in economic evaluations (August 2013) 

Belimumab for lupus
DSU report: Belimumab (Benlysta) for the treatment of systemic lupus erythematosus (SLE): Eliciting estimates of long-term treatment discontinuation rates (published online July 2013)


The DSU is currently involved in methods work in the following areas:

To receive notification when these reports or documents are uploaded on to this website, please join our mailing list by entering your details on the right of this page or follow us on Twitter @NICE_DSU